<?xml version="1.0" encoding="UTF-8"?>
<fig id="molecules-25-05414-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>(
   <bold>A</bold>) Transmission electron microscopy (TEM) image of nanostructured lipid carrier (NLC)-encapsulated 
   <italic>Brucea javanica</italic> oil (BJO) in phosphate-buffered saline (PBS) (pH 7.4). Red circles indicate representative NLC particles with spherical or elongated shapes; (
   <bold>B</bold>) Effects of blank NLCs as well as free and NLC-encapsulated BJO on the viability of human lung cancer cells after 48 h of incubation. Reproduced with permission from [
   <xref rid="B75-molecules-25-05414" ref-type="bibr">75</xref>]. (
   <bold>C</bold>) Schematic illustration of pH-dependent changes in the lipid crystalline nanoparticle (LCNP) morphology for anticancer applications. (
   <bold>D</bold>) pH-dependent in vitro release of doxorubicin (DOX) from LCNPs coloaded with DOX and BJO. Reproduced with permission from [
   <xref rid="B79-molecules-25-05414" ref-type="bibr">79</xref>].
  </p>
 </caption>
 <graphic xlink:href="molecules-25-05414-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
